Hiroyuki Shimada

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-<i>cis</i>-Retinoic Acid

Katherine K. Matthay, Judith G. Villablanca, Robert C. Seeger et al. · New England Journal of Medicine · 1999 · 1.9K citations · Full text

Medicine, Oncology, Pharmacology +7

The International Neuroblastoma Pathology Classification (the Shimada system)

Hiroyuki Shimada, Inge M. Ambros, Louis P. Dehner et al. · Cancer · 1999 · 1K citations

Medicine, Oncology, Pathology +17

Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of Neuroblastomas

Hiroyuki Shimada, Jane Chatten, William A. Newton et al. · JNCI Journal of the National Cancer Institute · 1984 · 869 citations

Medicine, Oncology, Pathology +16

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-<i>cis</i>-Retinoic Acid: A Children's Oncology Group Study

Katherine K. Matthay, C. Patrick Reynolds, Robert C. Seeger et al. · Journal of Clinical Oncology · 2009 · 856 citations

Medicine, Oncology, Chemotherapy +6

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease

Nicolas R. Barthélemy, Yan Li, Nelly Joseph‐Mathurin et al. · Nature Medicine · 2020 · 664 citations · Full text

Life Sciences, Biochemistry, Neuroscience +14